Dr. Gabor Brasnjo focuses on patent prosecution, strategic patent counseling, and intellectual property due diligence matters broadly in the life sciences sector, with an emphasis in the biotechnology and pharmaceutical industries.
Prior to joining the firm, Gabor was an associate at two large law firms, where he gained experience drafting U.S. and international patent applications; prosecuting pending U.S. patent applications; managing U.S., international, and foreign patent portfolios in collaboration with foreign associates worldwide; and conducting complicated due diligence analyses, including freedom-to-operate and patent landscape reviews.
Gabor also has counseled clients on various intellectual property provisions, including in employment, licensing, sales, and merger agreements. He has assisted clients working in a broad range of technologies related to the life sciences, including biologics such as antibodies and vaccines, therapeutic compositions and regimens, cell culture and imaging, sequencing, genome editing, and personalized medicine.
During law school, Gabor completed comprehensive freedom to-operate analyses on the CRISPR-associated protein-based targeted genome editing core technologies of a successful early biotech start-up company in the field under the formal supervision of outside counsel.
Before embarking on a legal career, Gabor conducted doctoral research at UCLA and completed postdoctoral fellowships at Weill Cornell Medical College and Stanford University, utilizing a multitude of techniques encompassing biochemistry, molecular biology, electrophysiology, advanced microscopy, and behavior analysis in projects leading to original scientific research publications.
- University of California, Hastings College of the Law; J.D.
- University of California, Los Angeles; Ph.D., Neurobiology
- San Francisco State University; B.S., Cell & Molecular Biology; Chemistry
- U.S. Patent & Trademark Office
Rate : $$$